Sweden-based Qbtech has received an FDA 510(k) clearance for an online tool, called QbCheck, that offers clinical decision-making support for diagnosing and treating children with ADHD. According to ...

HOUSTON--(BUSINESS WIRE)--Qbtech, the global leader in objective ADHD testing, today announced its one millionth patient milestone, amassing one of the most extensive data sets of patients tested for ...

HOUSTON--(BUSINESS WIRE)--Qbtech, the global leader in objective ADHD testing, today announced the launch of its new grant program, QbAccess. Created to make ADHD testing and care more accessible to ...

The MarketWatch News Department was not involved in the creation of this content. HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Qbtech, a leader in objective ADHD assessment technology, announced new ...

In response to the recent arrests of Done founder Ruthia He and clinical leader David Brody for the company's alleged stimulant prescription practices, Qbtech, the global leader in objective ADHD ...

A new study cautions against using the QbTest as a standalone diagnostic or screening tool for ADHD. Rather, the study authors highlight the intended use of the QbTest as a component of a full ...

The U.K. National Institute for Health and Care Excellence endorsed the Qb Test by Qbtech AB of Stockholm to aid in diagnosis of attention deficit/hyperactivity disorder in those aged 6 to 17.

HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Qbtech, a leader in objective ADHD assessment technology, announced new study findings demonstrating a strong correlation between changes in QbCheck ...